BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34519454)

  • 21. Application of contrast-enhanced CT radiomics in prediction of early recurrence of locally advanced oesophageal squamous cell carcinoma after trimodal therapy.
    Tang S; Ou J; Liu J; Wu YP; Wu CQ; Chen TW; Zhang XM; Li R; Tang MJ; Yang LQ; Tan BG; Lu FL; Hu J
    Cancer Imaging; 2021 May; 21(1):38. PubMed ID: 34039403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting response to radiotherapy of head and neck squamous cell carcinoma using radiomics from cone-beam CT images.
    Sellami S; Bourbonne V; Hatt M; Tixier F; Bouzid D; Lucia F; Pradier O; Goasduff G; Visvikis D; Schick U
    Acta Oncol; 2022 Jan; 61(1):73-80. PubMed ID: 34632924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

  • 24. CT imaging during treatment improves radiomic models for patients with locally advanced head and neck cancer.
    Leger S; Zwanenburg A; Pilz K; Zschaeck S; Zöphel K; Kotzerke J; Schreiber A; Zips D; Krause M; Baumann M; Troost EGC; Richter C; Löck S
    Radiother Oncol; 2019 Jan; 130():10-17. PubMed ID: 30087056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does Dual-Energy Computed Tomography Material Decomposition Improve Radiomics Capability to Predict Survival in Head and Neck Squamous Cell Carcinoma Patients? A Preliminary Investigation.
    Bernatz S; Böth I; Ackermann J; Burck I; Mahmoudi S; Lenga L; Martin SS; Scholtz JE; Koch V; Grünewald LD; Koch I; Stöver T; Wild PJ; Winkelmann R; Vogl TJ; Pinto Dos Santos D
    J Comput Assist Tomogr; 2024 Mar-Apr 01; 48(2):323-333. PubMed ID: 38013237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A computed tomography-based radiomics signature for predicting expression of programmed death ligand 1 in head and neck squamous cell carcinoma.
    Zheng YM; Yuan MG; Zhou RQ; Hou F; Zhan JF; Liu ND; Hao DP; Dong C
    Eur Radiol; 2022 Aug; 32(8):5362-5370. PubMed ID: 35298679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Technical note: On the development of an outcome-driven frequency filter for improving radiomics-based modeling of human papillomavirus (HPV) in patients with oropharyngeal squamous cell carcinoma.
    Bagher-Ebadian H; Zhu S; Siddiqui F; Lu M; Movsas B; Chetty IJ
    Med Phys; 2021 Nov; 48(11):7552-7562. PubMed ID: 34390003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status.
    Ou D; Blanchard P; Rosellini S; Levy A; Nguyen F; Leijenaar RTH; Garberis I; Gorphe P; Bidault F; Ferté C; Robert C; Casiraghi O; Scoazec JY; Lambin P; Temam S; Deutsch E; Tao Y
    Oral Oncol; 2017 Aug; 71():150-155. PubMed ID: 28688683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Constrast-enhanced computed tomography radiomics predicts CD27 expression and clinical prognosis in head and neck squamous cell carcinoma.
    Wang F; Zhang W; Chai Y; Wang H; Liu Z; He Y
    Front Immunol; 2022; 13():1015436. PubMed ID: 36458007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic resonance imaging based radiomics signature for the preoperative discrimination of stage I-II and III-IV head and neck squamous cell carcinoma.
    Ren J; Tian J; Yuan Y; Dong D; Li X; Shi Y; Tao X
    Eur J Radiol; 2018 Sep; 106():1-6. PubMed ID: 30150029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blockade of adenosine A2A receptor enhances CD8
    Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
    Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction of an enhanced computed tomography radiomics model for non-invasively predicting granzyme A in head and neck squamous cell carcinoma by machine learning.
    Hang R; Bai G; Sun B; Xu P; Sun X; Yan G; Zhang W; Wang F
    Eur Arch Otorhinolaryngol; 2023 Jul; 280(7):3353-3364. PubMed ID: 36920557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multimodal Imaging With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging to Detect Extracapsular Extension in Head and Neck Cancer.
    Sheppard SC; Giger R; Bojaxhiu B; Sachpekidis C; Dammann F; Dettmer MS; Arnold A; Wartenberg J; Nisa L
    Laryngoscope; 2021 Jan; 131(1):E163-E169. PubMed ID: 32142169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PET/CT Versus Standard Imaging for Prediction of Survival in Patients with Recurrent Head and Neck Squamous Cell Carcinoma.
    Rohde M; Nielsen AL; Pareek M; Johansen J; Sørensen JA; Diaz A; Nielsen MK; Christiansen JM; Asmussen JT; Nguyen N; Gerke O; Thomassen A; Alavi A; Høilund-Carlsen PF; Godballe C
    J Nucl Med; 2019 May; 60(5):592-599. PubMed ID: 30315144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiomic biomarkers for head and neck squamous cell carcinoma.
    Tanadini-Lang S; Balermpas P; Guckenberger M; Pavic M; Riesterer O; Vuong D; Bogowicz M
    Strahlenther Onkol; 2020 Oct; 196(10):868-878. PubMed ID: 32495038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative Radiomic Approach to Evaluate Tumor-Infiltrating CD8
    Liao H; Zhang Z; Chen J; Liao M; Xu L; Wu Z; Yuan K; Song B; Zeng Y
    Ann Surg Oncol; 2019 Dec; 26(13):4537-4547. PubMed ID: 31520208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Machine learning-based CT texture analysis to predict HPV status in oropharyngeal squamous cell carcinoma: comparison of 2D and 3D segmentation.
    Ren J; Yuan Y; Qi M; Tao X
    Eur Radiol; 2020 Dec; 30(12):6858-6866. PubMed ID: 32591885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A CT-based radiomics signature for preoperative discrimination between high and low expression of programmed death ligand 1 in head and neck squamous cell carcinoma.
    Zheng YM; Zhan JF; Yuan MG; Hou F; Jiang G; Wu ZJ; Dong C
    Eur J Radiol; 2022 Jan; 146():110093. PubMed ID: 34890937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) patients.
    Alfieri S; Romanò R; Bologna M; Calareso G; Corino V; Mirabile A; Ferri A; Bellanti L; Poli T; Marcantoni A; Grosso E; Tarsitano A; Battaglia S; Blengio F; De Martino I; Valerini S; Vecchio S; Richetti A; Deantonio L; Martucci F; Grammatica A; Ravanelli M; Ibrahim T; Caruso D; Locati LD; Orlandi E; Bossi P; Mainardi L; Licitra LF
    Acta Oncol; 2021 Sep; 60(9):1192-1200. PubMed ID: 34038324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of Genetic Alterations in Oncogenic Signaling Pathways in Squamous Cell Carcinoma of the Head and Neck: Radiogenomic Analysis Based on Computed Tomography Images.
    Wu L; Lin P; Zhao Y; Li X; Yang H; He Y
    J Comput Assist Tomogr; 2021 Nov-Dec 01; 45(6):932-940. PubMed ID: 34469904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.